Exane Derivatives’s SLB Ltd SLB Stock Holding History

Exane Derivatives’s Portfolio SLB Stock Details SLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$675K	Sell	18,872 -17,866	-49%	-$745K	0.39%	59
2022 Q1	$1.52M	Buy	36,738 +19,403	+112%	+$761K	0.43%	46
2021 Q4	$519K	Sell	17,335 -38,527	-69%	-$1.21M	0.13%	169
2021 Q3	$1.66M	Buy	55,862 +85	+0.2%	+$2.44K	0.4%	49
2021 Q2	$1.71M	Buy	55,777 +6,660	+14%	+$205K	0.39%	49
2021 Q1	$1.34M	Buy	49,117 +11,008	+29%	+$290K	0.38%	61
2020 Q4	$832K	Buy	38,109 +10,166	+36%	+$192K	0.24%	103
2020 Q3	$435K	Sell	27,943 -14,677	-34%	-$273K	0.13%	147
2020 Q2	$784K	Buy	42,620 +18,113	+74%	+$317K	0.21%	99
2020 Q1	$331K	Sell	24,507 -32,616	-57%	-$944K	0.09%	150
2019 Q4	$2.19M	Buy	+57,123	New	+$2.04M	0.41%	77
2019 Q3	–	Sell	-35,862	Closed	-$1.31M	–	693
2019 Q2	$1.42M	Sell	35,862 -63,251	-64%	-$2.55M	0.25%	82
2019 Q1	$4.32M	Buy	99,113 +98,472	+15,362%	+$4.26M	0.85%	26
2018 Q4	$23.1K	Buy	+641	New	+$31.6K	﹤0.01%	426
2018 Q2	–	Sell	-5,758	Closed	-$358K	–	701
2018 Q1	$358K	Buy	+5,758	New	+$402K	0.07%	181
2016 Q2	–	Sell	-4,156	Closed	-$307K	–	619
2016 Q1	$307K	Buy	4,156 +4,005	+2,652%	+$282K	0.04%	169
2015 Q4	$10.5K	Buy	+151	New	+$11.3K	﹤0.01%	322
2015 Q3	–	Sell	-4,140	Closed	-$357K	–	568
2015 Q2	$357K	Buy	+4,140	New	+$374K	0.04%	168

Other funds holding SLB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Exane Derivatives's SLB Position: Q2 2022 in Review

Exane Derivatives reduced its SLB Ltd (SLB) stake by 49% in Q2 2022, selling an estimated $745K and leaving 18,872 shares worth $675K. The position accounts for 0.39% of the portfolio, ranked #59.

Exane Derivatives first reported a position in SLB in Q2 2015 and has held it in 18 quarters since. The position peaked at $4.32M in Q1 2019. 1,264 funds tracked by Wall St. Rank hold SLB as of Q2 2022.

Exane Derivatives held 18,872 shares of SLB Ltd worth $675K as of Q2 2022.
Exane Derivatives sold 17,866 SLB Ltd shares in Q2 2022, an estimated $745K.
SLB Ltd made up 0.39% of Exane Derivatives's portfolio in Q2 2022, its #59 holding.
Exane Derivatives first reported a position in SLB Ltd in Q2 2015 and has held it in 18 quarters since.
Exane Derivatives's SLB Ltd position peaked at $4.32M in Q1 2019.
1,264 funds tracked by Wall St. Rank held SLB Ltd as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.